Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Department of Medical Laboratory Science and Biotechnology, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
J Dermatol Sci. 2019 Dec;96(3):159-167. doi: 10.1016/j.jdermsci.2019.11.004. Epub 2019 Nov 13.
Macrophages play important roles during wound healing, and delayed healing in diabetics is associated with sustained inflammation. M1 type macrophage is recognized to secrete excessive amount of tumor necrosis factor-alpha (TNF-α) as compared to its M2 counterpart.
We hypothesized that macrophage polarization is different between diabetic and normal rats during skin wounding and has direct impact on keratinocyte function in the context of re-epithelialization.
Skin wounds were created in diabetic and control rats. The phenotypes of infiltrating macrophages, the levels of TNF-α, and the rate of wound closure were determined. Using cell model, the effects of M1 type macrophage on keratinocyte migration were evaluated, and the potential regulatory pathways were determined.
The percentage of M1 macrophages and the levels of TNF-α expression were significantly higher in the perilesional area of diabetic rats as compared to control. The condition media (CM) from M1 type macrophage upregulated tissue inhibitor metalloproteinases (TIMP)-1 expression in keratinocytes and significantly reduced keratinocyte migratory capacity. Addition of neutralizing TNF-α antibody to the CM or gene-silencing of TIMP1 in keratinocytes restored the keratinocyte migratory capacity. Treating wounds of diabetic rats with TNF-α antagonist improved the wound healing process.
In summary, high glucose wound environment harbored more M1 macrophages infiltration, an event that created excess TNF-α micro-environment. TNF-α upregulated TIMP1 expression in keratinocytes and resulted in impaired keratinocyte migration. Taken together, these events contributed to impaired wound healing during diabetic condition, and targeting TNF-α is a potential therapeutic option to improve diabetic wound healing.
巨噬细胞在伤口愈合过程中发挥重要作用,糖尿病患者的愈合延迟与持续的炎症有关。与 M2 型巨噬细胞相比,M1 型巨噬细胞被认为会分泌过量的肿瘤坏死因子-α(TNF-α)。
我们假设在皮肤创伤过程中,糖尿病和正常大鼠的巨噬细胞极化状态不同,并直接影响上皮化过程中的角质形成细胞功能。
在糖尿病和对照组大鼠中创建皮肤伤口。确定浸润巨噬细胞的表型、TNF-α的水平以及伤口闭合率。使用细胞模型评估 M1 型巨噬细胞对角质形成细胞迁移的影响,并确定潜在的调节途径。
与对照组相比,糖尿病大鼠损伤周围区域的 M1 型巨噬细胞百分比和 TNF-α表达水平显著升高。M1 型巨噬细胞的条件培养基(CM)上调了角质形成细胞中组织抑制剂金属蛋白酶 1(TIMP-1)的表达,并显著降低了角质形成细胞的迁移能力。在 CM 中添加中和 TNF-α 抗体或在角质形成细胞中基因沉默 TIMP1 恢复了角质形成细胞的迁移能力。用 TNF-α 拮抗剂治疗糖尿病大鼠的伤口改善了伤口愈合过程。
总之,高糖的伤口环境中存在更多的 M1 型巨噬细胞浸润,这一事件产生了过多的 TNF-α微环境。TNF-α 上调了角质形成细胞中 TIMP1 的表达,导致角质形成细胞迁移受损。综上所述,这些事件导致糖尿病状态下伤口愈合受损,靶向 TNF-α是改善糖尿病伤口愈合的潜在治疗选择。